Outcomes of mild cognitive impairment by definition: a population study
TB-500 acts more broadly on cell migration, telling repair cells to travel to where they are needed, supporting muscle and soft tissue regeneration and modulating the inflammatory cascade systemically
The anti-inflammatory mechanisms also complement each other
None of these routes are approved for clinical or therapeutic use in humans, and all remain experimental
In the clinical trials with the EGRIFTA 1 mg/vial formulation, anti-tesamorelin IgG antibodies were detected in 50% of patients who received EGRIFTA for 26 weeks and 47% of patients who received EGRIFTA for 52 weeks
Statistical analysis Descriptive statistics were calculated using mean and standard deviation (SD) or median and interquartile range (IQR) for continuous variables, as appropriate for the normality of the distribution, and using proportions for dichotomous and categorical variables